Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin
Monday, July 13th, 2020
Manga Motrapu, Monika Katarzyna Swiderska, Irene Mesas, Julian Aurelio Marschner, Yutian Lei, Laura Martinez Valenzuela, Jia Fu, Kyung Lee, Maria Lucia Angelotti, Giulia Antonelli, Paola
The Effects of Chronic Dapagliflozin Treatment on the Renal Microvasculature in a Rat Model of Type 2 Diabetes
Wednesday, June 10th, 2020
Connie Ow, Vijayakumar Sukumaran, Jennifer Ngo, Cheng Kun Du, Akihiro Fujiwara, Hirotsugu Tsuchimochi, Hiroshi Hosoda, Roger Evans, James Pearson, “The Effects of Chronic Dapagliflozin Treatment
Revisiting Experimental Models of Diabetic Nephropathy
Tuesday, June 2nd, 2020
Anna Giralt-López, Mireia Molina-Van den Bosch, Ander Vergara, Clara García-Carro, Daniel Seron, Conxita Jacobs-Cachá, and Maria José Soler, “Revisiting Experimental Models of Diabetic Nephropathy,” International
Soluble (pro)renin receptor treats metabolic syndrome in mice with diet-induced obesity via interaction with PPARγ
Wednesday, April 15th, 2020
Fei Wang, Renfei Luo, Chang-Jiang Zou, Shiying Xie, Kexin Peng, Long Zhao, Kevin T. Yang, Chuanming Xu, and Tianxin Yang, “Soluble (pro)renin receptor treats metabolic
Rapid Progression of Glomerulosclerosis due to Concurrent Diabetes and Hypertension Correlates with Podocyte Damage Shown by Expansion Microscopy
Tuesday, December 17th, 2019
Yalcin Kuzay, Euan Clark, Sara Medina Balbuena, Benito Yard, John Mullins, Wilhelm Kriz, Hermann-Josef Gröne, Sigrid C. Hoffmann, “Rapid Progression of Glomerulosclerosis due to Concurrent
Restricted Access Matching Human Unilateral AKI, a Reverse Translational Approach to Investigate Kidney Recovery after Ischemia
Friday, December 13th, 2019
Danielle E. Soranno, Hyo-Wook Gil, Lara Kirkbride-Romeo, Christopher Altmann, John R. Montford, Haichun Yang, Ani Levine, Jane Buchanan and Sarah Faubel, “Restricted Access Matching Human
Whole-Kidney 3D Imaging and Transcriptome Assessment in the UNxdb/db Mouse Model of Diabetic Nephropathy
Wednesday, December 4th, 2019
Diabetic Nephropathy Frederikke E. Sembach, Brandon B. Boland, Lisbeth N. Fink, Urmas Roostalu, Jacob L. Skytte, Thomas Secher, Keld Fosgerau, Niels Vrang, Jacob Jelsing, Jacob
The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease
Tuesday, December 3rd, 2019
Masahiro Eriguchi, Ellen A. Bernstein, Luciana C. Veiras, Zakir Khan, Duo Yao Cao, Sebastien Fuchs, Alicia A. McDonough, Jorge E. Toblli, Romer A. Gonzalez-Villalobos, Kenneth
Compensatory mechanisms for methylglyoxal detoxification in experimental & clinical diabetes
Tuesday, November 26th, 2019
Dagmar Schumacher, Jakob Morgenstern, Yoko Oguchi, Nadine Volk, Stefan Kopf, Jan Benedikt Groener, Peter Paul Nawroth, Thomas Fleming, Marc Freichel, “Compensatory mechanisms for methylglyoxal detoxification
Dapagliflozin Reduces Glomerular Hyperfiltration and Improves Urine Parameters in db/db Mice on High Protein Diet: A 4-week Model of Diabetic Nephropathy
Monday, November 25th, 2019
Francois Briand, Sisse A. Nørgaard, Noémie Burr, Clément Costard, Emmanuel Brousseau, Nourdine Faresse, Fredrik Wolfhagen Sand, Thierry Sulpice, “Dapagliflozin Reduces Glomerular Hyperfiltration and Improves Urine
Glomerular Injury and Progressive Cardiac Dysfunction in the Obese ZSF1 Rat, a New Model of Diabetic Nephropathy and Heart Failure with Preserved Ejection Fraction
Thursday, November 14th, 2019
Elyse Di marco, Erik Michaëlsson, Charlotte Ericson, Margareta Behrendt, Maria Stromstedt, Magnus Soderberg, Johannes Wikstrom, Anna Granqvist, “Glomerular Injury and Progressive Cardiac Dysfunction in the
Losartan improves renal function and pathology in obese ZSF-1 rats
Friday, November 8th, 2019
Zhi Su, Deborah Widomski, Artur Nikkel, Laura Lets, Marian Namovic, Diana Donnelly-Roberts, Murall Gopalakrishnan, Steve McGaraughty, “Losartan improves renal function and pathology in obese ZSF-1
An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model
Sunday, October 13th, 2019
Xiaoyan Zhou, Ji Zhang, Robin Haimbach, Wei Zhu, Rosemary Mayer-Ezell, Margarita Garcia-Calvo, Elizabeth Smith, Olga Price, Yanquig Kan, Emanuel Zycband, Yonghua Zhu, Maarten Hoek, Jason
Renal Tubular ACE-Mediated Tubular Injury is The Major Contributor to Microalbuminuria in Early Diabetic Nephropathy
Friday, October 4th, 2019
Masahiro Eriguchi, Mercury Lin, Michifumi Yamashita, Tuantuan V. Zhao, Zakir Khan, Ellen A. Bernstein, Susan B Gurley, Romer A. Gonzalez-Villalobos, Kenneth E. Bernstein, Jorge Fernando
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes
Tuesday, October 1st, 2019
Micheal S. Ward, Nicole B. Flemming, Linda A. Gallo, Amelia K. Fotheringham, Domenica A. McCarthy, Aowen Zhuang, Peter H. Tang, Danielle J. Borg1, Hannah Shaw,
Maternal glucose intolerance reduces offspring nephron endowment and increases glomerular volume in adult offspring
Monday, September 16th, 2019
Hokke S., Arias N., Armitage J.A., Puelles V.G., Fong K., Geraci S., Gretz N., Bertram J.F., Cullen-McEwen L.A., “Maternal glucose intolerance reduces offspring nephron endowment
Maternal Glucose Intolerance Reduces Offspring Nephron Endowment and Increases Glomerular Volume in Adult Offspring
Saturday, September 14th, 2019
Hokke S, Arias N, Armitage JA, Puelles VG, Fong K, Geraci S, Gretz N, Bertram JF, Cullen-McEwen LA, “Maternal Glucose Intolerance Reduces Offspring Nephron Endowment
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
Tuesday, September 10th, 2019
Gallo LA, Ward MS, Fotheringham AK, Zhuang A, Borg DJ, Flemming NB, Harvie BM, Kinneally TL, Yeh SM, McCarthy DA, Koepsell H, Vallon V, Pollock
PBI-4425, A novel anti-inflamantory/fibrotic compound, improves kidney function and glomerular integrity in the diabetic DB/DB mouse mode
Sunday, September 8th, 2019
Lyne Gagnon, Kathy Hince, François Sarra-Bournet, Liette Gervais, Alexandra Felton, Alexandre Laverdure, William Gagnon, Martin Leduc, Lilianne Geerts, Pierre Laurin, Brigitte Grouix, “PBI-4425, A novel
A Potent Pan-AMPK Activator Improves Renal Structure and Function in the ZSF-1 Rat Model of Diabetic Nephropathy
Friday, September 6th, 2019
Hoek M., Zhou X., Haimbach R. E., Muise E., Ma L-J, Price O., Forrest G.M., Herath K., Zycband E., Ruben Z., Zhu Y., Pinto S.,
Renal Olfactory Receptor 1393 Contributes to Glucose Reabsorption
Thursday, September 5th, 2019
Shepard B. D., Cheval L., Zita P. L., Firestein S., Koepsel H., Doucet A., Pluznick J. L., “Renal Olfactory Receptor 1393 Contributes to Glucose Reabsorption,”
Renal Tubular ACE Affects Microalbuminuria in Early Diabetic Nephropathy
Wednesday, September 4th, 2019
Eriguchi M., Giani J.F., Lin M.Y., Zhao T., Khan Z., Bernstein E.A., Shen X., Gonzalez-Villalobos R.A., Bernstein K.E., “Renal Tubular ACE Affects Microalbuminuria in Early
A Longitudinal Study on Kidney Function, Pathology, and Multiple Urinary Biomarkers in ZSF1 Rat Model of Type II Diabetic Nephropathy
Wednesday, August 21st, 2019
Z. Su, D. Widomski, M. T. Namovic, D. L. Donnelly‑Roberts, L. Leys, K. Salte, A. L. Nikkel, L. Olson, J. Ma, T. A.Esbenshade, S. McGaraughty,
